FindTrial
Sign In

Prognostic Implications of Ductal Carcinoma in Situ Components in BRCA1/2-Positive Breast Cancer: a Retrospective Cohort Study

Prognostic effect of ductal carcinoma in situ in breast cancer with breast cancer susceptibility gene (BRCA) 1/2 mutations

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009513
Enrollment
201
Registered
2024-06-05
Start date
2023-10-01
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seoul National University Bundang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Breast cancer patients over 18 years old who had available results for BRCA mutations

Exclusion criteria

Exclusion criteria: Patients without BRCA mutation testing

Design outcomes

Primary

MeasureTime frame
Recurrence-free survival—

Secondary

MeasureTime frame
Risk factors for recurrence of breast cancer—

Countries

Korea, Republic of

Contacts

Public ContactKyung-Hwak Yoon

Seoul National University Bundang Hospital

yoonkh1986@gmail.com+82-31-787-7099

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026